1610414-00-0
Chemical Structure
EC1167
- No. CAS: 1610414-00-0
- Formula:C33H45N7O17S
- Molecular Weight:843.81
IUPAC Name: (9S,13S)-1-(4-(2-(((S)-3-carboxy-1-(((S)-3-carboxy-1-(((R)-1-carboxy-2-mercaptoethyl)amino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)amino)-2-oxoethyl)phenyl)-3,11-dioxo-2,4,10,12-tetraazapentadecane-9,13,15-tricarboxylic acid
InChIKey: NAFZHTBVPLIASG-YFNVTMOMSA-N
SMILES: SC[C@@H](C(O)=O)NC([C@H](CC(O)=O)NC([C@H](CC(O)=O)NC(CC1=CC=C(CNC(NCCCC[C@@H](C(O)=O)NC(N[C@H](C(O)=O)CCC(O)=O)=O)=O)C=C1)=O)=O)=O
Biological Activity: EC1167 is the linker for EC1169. EC1169 is prostate-specific membrane antigen targeting-tubulysin conjugate. EC1169 has the potential to treat recurrent metastatic, castration-resistant prostate cancer (MCRPC)[1].
| Referencia número | Nombre del producto | Pureza | Descripciòn | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
EC1167 | EC1167 is the linker for EC1169. EC1169 is prostate-specific membrane antigen targeting-tubulysin conjugate. EC1169 has the potential to treat recurrent metastatic, castration-resistant prostate cancer (MCRPC). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
